DECIBEL CANNABIS CO INC (DB.CA) Fundamental Analysis & Valuation

TSX-V:DB • CA2434371001

Current stock price

0.13 CAD
0 (0%)
Last:

This DB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DB.CA Profitability Analysis

1.1 Basic Checks

  • DB had negative earnings in the past year.
  • In the past year DB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: DB reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: DB reported negative operating cash flow in multiple years.
DB.CA Yearly Net Income VS EBIT VS OCF VS FCFDB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • With an excellent Return On Assets value of 7.97%, DB belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • DB has a better Return On Equity (18.35%) than 90.63% of its industry peers.
Industry RankSector Rank
ROA 7.97%
ROE 18.35%
ROIC N/A
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
DB.CA Yearly ROA, ROE, ROICDB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.67%, DB belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
  • DB's Profit Margin has improved in the last couple of years.
  • DB has a worse Gross Margin (21.98%) than 68.75% of its industry peers.
  • In the last couple of years the Gross Margin of DB has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 10.67%
GM 21.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
DB.CA Yearly Profit, Operating, Gross MarginsDB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

2

2. DB.CA Health Analysis

2.1 Basic Checks

  • DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DB has been increased compared to 1 year ago.
  • The number of shares outstanding for DB has been increased compared to 5 years ago.
  • The debt/assets ratio for DB has been reduced compared to a year ago.
DB.CA Yearly Shares OutstandingDB.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
DB.CA Yearly Total Debt VS Total AssetsDB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • DB has an Altman-Z score of 1.06. This is a bad value and indicates that DB is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.06, DB is doing good in the industry, outperforming 71.88% of the companies in the same industry.
  • The Debt to FCF ratio of DB is 18.67, which is on the high side as it means it would take DB, 18.67 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 18.67, DB is in line with its industry, outperforming 59.38% of the companies in the same industry.
  • DB has a Debt/Equity ratio of 0.54. This is a neutral value indicating DB is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.54, DB perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 18.67
Altman-Z 1.06
ROIC/WACCN/A
WACC7.78%
DB.CA Yearly LT Debt VS Equity VS FCFDB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • DB has a Current Ratio of 1.34. This is a normal value and indicates that DB is financially healthy and should not expect problems in meeting its short term obligations.
  • DB's Current ratio of 1.34 is on the low side compared to the rest of the industry. DB is outperformed by 62.50% of its industry peers.
  • A Quick Ratio of 0.61 indicates that DB may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, DB is doing worse than 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.61
DB.CA Yearly Current Assets VS Current LiabilitesDB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

8

3. DB.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 816.22% over the past year.
  • Measured over the past years, DB shows a very strong growth in Earnings Per Share. The EPS has been growing by 90.70% on average per year.
  • The Revenue has grown by 15.11% in the past year. This is quite good.
  • Measured over the past years, DB shows a very strong growth in Revenue. The Revenue has been growing by 71.51% on average per year.
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%

3.2 Future

  • Based on estimates for the next years, DB will show a very strong growth in Earnings Per Share. The EPS will grow by 71.68% on average per year.
  • Based on estimates for the next years, DB will show a quite strong growth in Revenue. The Revenue will grow by 10.33% on average per year.
EPS Next Y100%
EPS Next 2Y101%
EPS Next 3Y71.68%
EPS Next 5YN/A
Revenue Next Year23.69%
Revenue Next 2Y20.05%
Revenue Next 3Y15.54%
Revenue Next 5Y10.33%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DB.CA Yearly Revenue VS EstimatesDB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
DB.CA Yearly EPS VS EstimatesDB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 2026 2027 0 -0.05 -0.1 -0.15

5

4. DB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Forward Earnings ratio of 6.37, the valuation of DB can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, DB is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
  • DB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.10.
Industry RankSector Rank
PE N/A
Fwd PE 6.37
DB.CA Price Earnings VS Forward Price EarningsDB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 30.61
EV/EBITDA N/A
DB.CA Per share dataDB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15

4.3 Compensation for Growth

  • DB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DB's earnings are expected to grow with 71.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101%
EPS Next 3Y71.68%

0

5. DB.CA Dividend Analysis

5.1 Amount

  • DB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DB.CA Fundamentals: All Metrics, Ratios and Statistics

DECIBEL CANNABIS CO INC

TSX-V:DB (4/7/2026, 7:00:00 PM)

0.13

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-19
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.83%
Ins Owner ChangeN/A
Market Cap75.02M
Revenue(TTM)109.31M
Net Income(TTM)11.66M
Analysts80
Price Target0.23 (76.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.87%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)7.97%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-13.84%
Max Revenue beat(4)7.97%
Revenue beat(8)2
Avg Revenue beat(8)-5.36%
Revenue beat(12)5
Avg Revenue beat(12)1.08%
Revenue beat(16)5
Avg Revenue beat(16)-1.07%
PT rev (1m)-15.64%
PT rev (3m)-15.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)N/A
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.37
P/S 0.69
P/FCF 30.61
P/OCF 18.96
P/B 1.18
P/tB 1.19
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY15.69%
FCF(TTM)0
FCFY3.27%
OCF(TTM)0.01
OCFY5.27%
SpS0.19
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 18.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.67%
GM 21.98%
FCFM 2.24%
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 18.67
Debt/EBITDA N/A
Cap/Depr 23.63%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 21.01%
Current Ratio 1.34
Quick Ratio 0.61
Altman-Z 1.06
F-Score6
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)70.46%
Cap/Depr(5y)95.47%
Cap/Sales(3y)2.65%
Cap/Sales(5y)5.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y100%
EPS Next 2Y101%
EPS Next 3Y71.68%
EPS Next 5YN/A
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%
Revenue Next Year23.69%
Revenue Next 2Y20.05%
Revenue Next 3Y15.54%
Revenue Next 5Y10.33%
EBIT growth 1Y-65.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year307.59%
EBIT Next 3Y79.3%
EBIT Next 5Y46.66%
FCF growth 1Y-16.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.82%
OCF growth 3YN/A
OCF growth 5YN/A

DECIBEL CANNABIS CO INC / DB.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DECIBEL CANNABIS CO INC (DB.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DB.CA.


What is the valuation status of DECIBEL CANNABIS CO INC (DB.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to DECIBEL CANNABIS CO INC (DB.CA). This can be considered as Fairly Valued.


What is the profitability of DB stock?

DECIBEL CANNABIS CO INC (DB.CA) has a profitability rating of 4 / 10.


How financially healthy is DECIBEL CANNABIS CO INC?

The financial health rating of DECIBEL CANNABIS CO INC (DB.CA) is 2 / 10.